Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

BACKGROUND: Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. METHODS: We randomly assigned 247 adults with nonalcoholic steatohepatitis and without diabetes to receive pioglitazone at a dose of 30 mg...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sanyal, Arun J., Chalasani, Naga, Kowdley, Kris V., McCullough, Arthur, Diehl, Anna Mae, Bass, Nathan M., Neuschwander-Tetri, Brent A., Lavine, Joel E., Tonascia, James, Unalp, Aynur, Natta, Mark Van, Clark, Jeanne, Brunt, Elizabeth M., Kleiner, David E., Hoofnagle, Jay H., Robuck, Patricia R.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2928471/
https://ncbi.nlm.nih.gov/pubmed/20427778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0907929
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares